Aubrey Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,860
| Closed | -$3.58M | – | 67 |
|
|
2023
Q4 | $3.58M | Sell |
28,860
-600
| -2% | -$74.5K | 1.53% | 15 |
|
|
2023
Q3 | $2.44M | Sell |
29,460
-15,000
| -34% | -$1.24M | 1.4% | 17 |
|
|
2023
Q2 | $5.71M | Sell |
44,460
-3,800
| -8% | -$488K | 3.75% | 8 |
|
|
2023
Q1 | $5.61M | Hold |
48,260
| – | – | 3.25% | 9 |
|
|
2022
Q4 | $5.47M | Sell |
48,260
-3,600
| -7% | -$408K | 4.38% | 6 |
|
|
2022
Q3 | $4.18M | Sell |
51,860
-4,300
| -8% | -$346K | 3.58% | 7 |
|
|
2022
Q2 | $4.19M | Sell |
56,160
-5,600
| -9% | -$417K | 3.37% | 12 |
|
|
2022
Q1 | $7.9M | Sell |
61,760
-20,000
| -24% | -$2.56M | 4.51% | 5 |
|
|
2021
Q4 | $11M | Hold |
81,760
| – | – | 4.28% | 6 |
|
|
2021
Q3 | $11.2M | Hold |
81,760
| – | – | 3.52% | 7 |
|
|
2021
Q2 | $8.73M | Sell |
81,760
-6,000
| -7% | -$641K | 2.54% | 13 |
|
|
2021
Q1 | $7.89M | Hold |
87,760
| – | – | 2.22% | 13 |
|
|
2020
Q4 | $8.11M | Hold |
87,760
| – | – | 2.02% | 14 |
|
|
2020
Q3 | $9.04M | Sell |
87,760
-1,600
| -2% | -$165K | 2.8% | 10 |
|
|
2020
Q2 | $9.06M | Sell |
89,360
-48,000
| -35% | -$4.86M | 4.05% | 5 |
|
|
2020
Q1 | $9.25M | Sell |
137,360
-14,400
| -9% | -$970K | 5.72% | 5 |
|
|
2019
Q4 | $8.3M | Buy |
151,760
+13,600
| +10% | +$744K | 4.7% | 5 |
|
|
2019
Q3 | $5.15M | Buy |
138,160
+44,000
| +47% | +$1.64M | 3.15% | 10 |
|
|
2019
Q2 | $3.53M | Buy |
94,160
+17,156
| +22% | +$643K | 1.68% | 27 |
|
|
2019
Q1 | $2.29M | Buy |
+77,004
| New | +$2.29M | 1.1% | 32 |
|